Arcutis Biotherapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Arcutis Biotherapeutics has scheduled its 2026 Annual Meeting of Stockholders for June 5, 2026, to address director elections, auditor ratification, and executive compensation.
NASDAQ
Arcutis Biotherapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Arcutis Biotherapeutics announces its annual stockholders meeting to be held virtually on June 12, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
Arcutis Biotherapeutics, Inc. files a definitive proxy statement with the SEC.
NASDAQ
Arcutis Biotherapeutics announces its annual stockholders meeting to be held virtually on June 14, 2024, to vote on director elections, auditor ratification, and executive compensation.